Can a drug work a second time? trial tests retreatment for tough breast cancers
NCT ID NCT02514681
Summary
This study tested whether restarting a drug called pertuzumab, along with standard treatments, could help control advanced HER2-positive breast cancer that had previously been treated with it. It involved 226 women with advanced breast cancer. The goal was to see if this retreatment approach could slow cancer growth better than continuing treatment without pertuzumab.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-POSITIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aichi Cancer Center
Chikusa-ku, Aichi-ken, 4648681, Japan
-
Japan Breast Cancer Research Group
Chuo-ku, Nihonbashi, Koami-cho, Tokyo, 1030016, Japan
-
Kumamoto University Hospital
Kumamoto, Kumamoto, 8608556, Japan
Conditions
Explore the condition pages connected to this study.